Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Role of vaccines in urothelial carcinoma

Guru Sonpavde, MD, Dana-Farber Cancer Institute, Boston, MA, provides an overview of recent developments in the use of vaccines for patients with urothelial carcinoma, including neoantigen-based peptide vaccine approaches. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.